UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000027138
Receipt No. R000031092
Scientific Title Study on the effect of blood purification therapy on the immune system
Date of disclosure of the study information 2017/05/01
Last modified on 2019/04/29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on the effect of blood purification therapy on the immune system
Acronym Study on the effect of blood purification therapy on the immune system
Scientific Title Study on the effect of blood purification therapy on the immune system
Scientific Title:Acronym Study on the effect of blood purification therapy on the immune system
Region
Japan

Condition
Condition All diseases requiring blood purification therapy
Classification by specialty
Nephrology Neurology Clinical immunology
Intensive care medicine Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to investigate the effects on autoimmune diseases, renal failure, septicemia, etc. on the immune system brought about by blood purification therapy and to use it for the treatment and selection of the target disease is there.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Number og Myeroid-derived suppressor cells
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Cases in which various blood purification therapy is performed in our artificial kidney section and intensive care section.
Key exclusion criteria Cases in which consent was not obtained.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Shigeto Oda
Organization Chiba University Graduate school of medicine and Chiba University Hospital
Division name Department of Emergency and Critical Care Medicine an department of Artificial Kidney
Zip code
Address 1-8-1Inohana Chuoku Chiba City and Chiba,Japan
TEL 043-222-7171
Email nanayayacar@yahoo.co.jp

Public contact
Name of contact person
1st name
Middle name
Last name Hanae Wakabayashi
Organization Chiba University Graduate school of medicine and Chiba University Hospital
Division name Department of Emergency and Critical Care Medicine an department of Artificial Kidney
Zip code
Address 1-8-1Inohana Chuoku Chiba City and Chiba,Japan
TEL 043-222-7171
Homepage URL
Email nanayayacar@yahoo.co.jp

Sponsor
Institute Chiba-University Hospital
Institute
Department

Funding Source
Organization Scholarship donation
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 05 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2016 Year 09 Month 01 Day
Date of IRB
2016 Year 09 Month 01 Day
Anticipated trial start date
2016 Year 12 Month 08 Day
Last follow-up date
2019 Year 03 Month 30 Day
Date of closure to data entry
2019 Year 03 Month 30 Day
Date trial data considered complete
2019 Year 03 Month 30 Day
Date analysis concluded

Other
Other related information Blood tests before and after treatment, blood tests after remission are performed and data analysis is in progress.

Management information
Registered date
2017 Year 04 Month 26 Day
Last modified on
2019 Year 04 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031092

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.